Gabriele Ricci
CIK: 0001977815
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TAK
TAKEDA PHARMACEUTICAL CO LTD
Officer
Discretionary Trading P&L
Holdings
About Ricci Gabriele
Ricci Gabriele (SEC CIK 0001977815) files insider reports with the SEC as Chief Data & Tech. Officer of TAKEDA PHARMACEUTICAL CO LTD (TAK).
Signal8 holds 4 ownership filings by Ricci Gabriele (1 Form 3, 3 Form 4), filed between Mar 18, 2026 and Aug 12, 2026. Those filings report 3 transactions, from Apr 27, 2026 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ricci Gabriele's filings is in CAMBRIDGE, MA.
Recent filings by Ricci Gabriele
Other insiders filing for TAKEDA PHARMACEUTICAL CO LTD (TAK)
- Duprey Lauren Rusckowski, Chief Transformation Officer
- Plump Andrew Stewart, President, R&D
- Greenway Nicola Deidre Petal, Chief Human Resources Officer
- Farajallah Awny Samaan Botros, Chief Medical Officer
- Ibrahim Ramy Riad Ahmed, President, PDT BU
- Pacheco Rhonda Janice, President, U.S. Business Unit